March 17, 2023 02:14 PM EDT
FDA+

GAO on com­bo prod­uct patents: Stake­hold­ers split on need for Or­ange Book tweaks

Zachary Brennan

Senior Editor

The Gov­ern­ment Ac­count­abil­i­ty Of­fice (GAO) late Thurs­day re­leased a re­port eval­u­at­ing whether Or­ange Book patent list­ings re­lat­ed to drug-de­vice com­bi­na­tion prod­ucts …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Im­munol­o­gy biotech In­ma­gene to join Nas­daq through re­verse merg­er with what's left of Ike­na

A service from the Financial Times